Artigas L, Coma M, Matos-Filipe P, Aguirre-Plans J, et al. In-silico drug repurposing study predicts the combination of pirfenidone and melatonin as a promising candidate therapy to reduce SARS-CoV-2 infection progression and respiratory distress caused by cytokine storm. PLoS One 2020;15:e0240149.
PMID: 33006999